Business Description
Sandu Pharmaceuticals Ltd
ISIN : INE751D01014
Compare
Compare
Traded in other countries / regions
524703.India IPO Date
1994-09-12Description
Sandu Pharmaceuticals Ltd is a pharmaceutical company. It is principally engaged in the manufacturing and sales of Ayurvedic pharmaceutical products.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 6.45 | |||||
| Equity-to-Asset | 0.74 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 0.18 | |||||
| Interest Coverage | 26.98 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 3.89 | |||||
| Beneish M-Score | -2.34 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -5.7 | |||||
| 3-Year EBITDA Growth Rate | -4.8 | |||||
| 3-Year EPS without NRI Growth Rate | -0.7 | |||||
| 3-Year Book Growth Rate | -0.2 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 48.81 | |||||
| 9-Day RSI | 46.17 | |||||
| 14-Day RSI | 46.22 | |||||
| 6-1 Month Momentum % | -4.52 | |||||
| 12-1 Month Momentum % | -15.53 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.99 | |||||
| Quick Ratio | 1.27 | |||||
| Cash Ratio | 0.26 | |||||
| Days Inventory | 114.39 | |||||
| Days Sales Outstanding | 34.18 | |||||
| Days Payable | 57.14 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.42 | |||||
| Dividend Payout Ratio | 0.27 | |||||
| Forward Dividend Yield % | 1.42 | |||||
| 5-Year Yield-on-Cost % | 1.42 | |||||
| 3-Year Average Share Buyback Ratio | -6.8 | |||||
| Shareholder Yield % | 1.44 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 50.6 | |||||
| Operating Margin % | 2.61 | |||||
| Net Margin % | 2.16 | |||||
| FCF Margin % | -0.98 | |||||
| ROE % | 3.61 | |||||
| ROA % | 2.74 | |||||
| ROIC % | 2.72 | |||||
| ROC (Joel Greenblatt) % | 7.9 | |||||
| ROCE % | 5.18 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 19.18 | |||||
| PE Ratio without NRI | 19.18 | |||||
| Shiller PE Ratio | 39.65 | |||||
| Price-to-Owner-Earnings | 258.93 | |||||
| PS Ratio | 0.81 | |||||
| PB Ratio | 1.34 | |||||
| Price-to-Tangible-Book | 1.33 | |||||
| Price-to-Operating-Cash-Flow | 71.65 | |||||
| EV-to-EBIT | 23.8 | |||||
| EV-to-EBITDA | 18.25 | |||||
| EV-to-Revenue | 0.76 | |||||
| EV-to-FCF | -76.62 | |||||
| Price-to-Projected-FCF | 1 | |||||
| Price-to-Median-PS-Value | 1.59 | |||||
| Price-to-Graham-Number | 1.07 | |||||
| Price-to-Net-Current-Asset-Value | 5.03 | |||||
| Earnings Yield (Greenblatt) % | 4.2 | |||||
| FCF Yield % | -1.22 | |||||
| Forward Rate of Return (Yacktman) % | 4.27 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sandu Pharmaceuticals Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 677.767 | ||
| EPS (TTM) (₹) | 2.94 | ||
| Beta | 1.05 | ||
| Volatility % | 24.85 | ||
| 14-Day RSI | 46.22 | ||
| 14-Day ATR (₹) | 2.045531 | ||
| 20-Day SMA (₹) | 57.0575 | ||
| 12-1 Month Momentum % | -15.53 | ||
| 52-Week Range (₹) | 54 - 85 | ||
| Shares Outstanding (Mil) | 9.66 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sandu Pharmaceuticals Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sandu Pharmaceuticals Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sandu Pharmaceuticals Ltd Frequently Asked Questions
What is Sandu Pharmaceuticals Ltd(BOM:524703)'s stock price today?
The current price of BOM:524703 is ₹56.39. The 52 week high of BOM:524703 is ₹85.00 and 52 week low is ₹54.00.
When is next earnings date of Sandu Pharmaceuticals Ltd(BOM:524703)?
The next earnings date of Sandu Pharmaceuticals Ltd(BOM:524703) is .
Does Sandu Pharmaceuticals Ltd(BOM:524703) pay dividends? If so, how much?
The Dividend Yield %  of Sandu Pharmaceuticals Ltd(BOM:524703) is 1.42% (As of Today), Highest Dividend Payout Ratio of Sandu Pharmaceuticals Ltd(BOM:524703) was 0.5. The lowest was 0.27. And the median was 0.46. The  Forward Dividend Yield % of Sandu Pharmaceuticals Ltd(BOM:524703) is 1.42%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers